Global Biological Market/Monoclonal Antibodies Market Analysis 2019

Tutorials Get 15% Discount on First Report

The Monoclonal Antibodies market is expected to reach $183.35 billion by 2026 growing at a CAGR of 8.3% during 2018 to 2026. Monoclonal is a class of antibodies with identical offspring of a hybridoma. These are derived by cell division from a single parent cell. Monoclonal antibodies are used in the diagnosis of leukemia and more recently in the treatment of malignancies.

Factors such as constant innovation in drug development and discovery, increased need for personalized medicine, and growing R&D activities in genomics are driving the market growth. Though, the high cost of antibodies restrains the market growth. Moreover, the high rate of adoption of therapeutic antibodies and favourable regulatory policies are the opportunities for the monoclonal antibodies market.

Based on source type, the humanized segment is going to have a lucrative growth during the forecast period, owing to its extensive adoption in the treatment of various diseases including cancer, inflammatory, and autoimmune diseases.

The key vendors mentioned are Abbott Laboratories, GlaxoSmithKline Plc, Pfizer , Novartis International, Merck & Co Inc, Johnson & Johnson, Eli Lilly, Amgen Inc, Daiichi Sankyo, AstraZeneca Plc, Thermo Fisher Scientific, Biogen Idec Inc, Mylan N.V, Bayer AG, F.Hoffman-La Roche Ltd, and Bristol Myers Squibb.

Source Types Covered:
• Human
• Humanized
• Recombinant
• Chimeric
• Murine

Production Types Covered:
• In Vivo
• In Vitro

Indications Covered:
• Hematological Disorders
• Autoimmune Diseases
• Cancer
• Infectious Diseases
• Neurology
• Cardiovascular
• Microbial Diseases
• Inflammatory Diseases
• Respiratory Diseases

Applications Covered:
• Analytical & Chemical Uses
• Therapeutic
• Diagnostic

End Users Covered:
• Research Institutes
• Hospitals & Clinics

Regions Covered:
• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Key Questions Answered in this Report:
• How this market evolved since the year 2016
• Market size estimations, forecasts and CAGR for all the segments presented in the scope
• Key Market Developments and financials of the key players
• Opportunity Analysis for the new entrants
• SWOT Analysis of the key players
• Fastest growing markets analysed during the forecast period

Your Name:
Your Phone:
Company Name:
Country:
Your Email:
Description:

1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Monoclonal Antibodies Market, By Source Type
5.1 Introduction
5.2 Human
5.3 Humanized
5.4 Recombinant
5.5 Chimeric
5.6 Murine

6 Global Monoclonal Antibodies Market, By Production Type
6.1 Introduction
6.2 In Vivo
6.3 In Vitro

7 Global Monoclonal Antibodies Market, By Indication
7.1 Introduction
7.2 Hematological Disorders
7.3 Autoimmune Diseases
7.4 Cancer
7.5 Infectious Diseases
7.6 Neurology
7.7 Cardiovascular
7.8 Microbial Diseases
7.9 Inflammatory Diseases
7.10 Respiratory Diseases

8 Global Monoclonal Antibodies Market, By Application
8.1 Introduction
8.2 Analytical & Chemical Uses
8.3 Therapeutic
8.4 Diagnostic

9 Global Monoclonal Antibodies Market, By End User
9.1 Introduction
9.2 Research Institutes
9.3 Hospitals & Clinics

10 Global Monoclonal Antibodies Market, By Geography
10.1 North America
10.2 Europe
10.3 Asia Pacific
10.4 South America
10.5 Middle East & Africa

11 Strategic Benchmarking

12 Vendors Landscape
12.1 Abbott Laboratories
12.2 GlaxoSmithKline Plc
12.3 Pfizer
12.4 Novartis International
12.5 Merck & Co Inc
12.6 Johnson & Johnson
12.7 Eli Lilly
12.8 Amgen Inc
12.9 Daiichi Sankyo
12.10 AstraZeneca Plc
12.11 Thermo Fisher Scientific
12.12 Biogen Idec Inc
12.13 Mylan N.V.
12.14 Bayer AG
12.15 F.Hoffman-La Roche Ltd
12.16 Bristol Myers Squibb

List of Data Tables
1 Global Monoclonal Antibodies Market Outlook, By Region (2016-2026) ($MN)
2 Global Monoclonal Antibodies Market Outlook, By Source Type (2016-2026) ($MN)
3 Global Monoclonal Antibodies Market Outlook, By Human (2016-2026) ($MN)
4 Global Monoclonal Antibodies Market Outlook, By Humanized (2016-2026) ($MN)
5 Global Monoclonal Antibodies Market Outlook, By Recombinant (2016-2026) ($MN)
6 Global Monoclonal Antibodies Market Outlook, By Chimeric (2016-2026) ($MN)
7 Global Monoclonal Antibodies Market Outlook, By Murine (2016-2026) ($MN)
8 Global Monoclonal Antibodies Market Outlook, By Production Type (2016-2026) ($MN)
9 Global Monoclonal Antibodies Market Outlook, By In Vivo (2016-2026) ($MN)
10 Global Monoclonal Antibodies Market Outlook, By In Vitro (2016-2026) ($MN)
11 Global Monoclonal Antibodies Market Outlook, By Indication (2016-2026) ($MN)
12 Global Monoclonal Antibodies Market Outlook, By Hematological Disorders (2016-2026) ($MN)
13 Global Monoclonal Antibodies Market Outlook, By Autoimmune Diseases (2016-2026) ($MN)
14 Global Monoclonal Antibodies Market Outlook, By Cancer (2016-2026) ($MN)
15 Global Monoclonal Antibodies Market Outlook, By Infectious Diseases (2016-2026) ($MN)
16 Global Monoclonal Antibodies Market Outlook, By Neurology (2016-2026) ($MN)
17 Global Monoclonal Antibodies Market Outlook, By Cardiovascular (2016-2026) ($MN)
18 Global Monoclonal Antibodies Market Outlook, By Microbial Diseases (2016-2026) ($MN)
19 Global Monoclonal Antibodies Market Outlook, By Inflammatory Diseases (2016-2026) ($MN)
20 Global Monoclonal Antibodies Market Outlook, By Respiratory Diseases (2016-2026) ($MN)
21 Global Monoclonal Antibodies Market Outlook, By Application (2016-2026) ($MN)
22 Global Monoclonal Antibodies Market Outlook, By Analytical & Chemical Uses (2016-2026) ($MN)
23 Global Monoclonal Antibodies Market Outlook, By Therapeutic (2016-2026) ($MN)
24 Global Monoclonal Antibodies Market Outlook, By Diagnostic (2016-2026) ($MN)
25 Global Monoclonal Antibodies Market Outlook, By End User (2016-2026) ($MN)
26 Global Monoclonal Antibodies Market Outlook, By Research Institutes (2016-2026) ($MN)
27 Global Monoclonal Antibodies Market Outlook, By Hospitals & Clinics (2016-2026) ($MN)
28 North America Monoclonal Antibodies Market Outlook, By Country (2016-2026) ($MN)
29 North America Monoclonal Antibodies Market Outlook, By Source Type (2016-2026) ($MN)
30 North America Monoclonal Antibodies Market Outlook, By Production Type (2016-2026) ($MN)
31 North America Monoclonal Antibodies Market Outlook, By Indication (2016-2026) ($MN)
32 North America Monoclonal Antibodies Market Outlook, By Application (2016-2026) ($MN)
33 North America Monoclonal Antibodies Market Outlook, By End User (2016-2026) ($MN)
34 Europe Monoclonal Antibodies Market Outlook, By Country (2016-2026) ($MN)
35 Europe Monoclonal Antibodies Market Outlook, By Source Type (2016-2026) ($MN)
36 Europe Monoclonal Antibodies Market Outlook, By Production Type (2016-2026) ($MN)
37 Europe Monoclonal Antibodies Market Outlook, By Indication (2016-2026) ($MN)
38 Europe Monoclonal Antibodies Market Outlook, By Application (2016-2026) ($MN)
39 Europe Monoclonal Antibodies Market Outlook, By End User (2016-2026) ($MN)
40 Asia Pacific Monoclonal Antibodies Market Outlook, By Country (2016-2026) ($MN)
41 Asia Pacific Monoclonal Antibodies Market Outlook, By Source Type (2016-2026) ($MN)
42 Asia Pacific Monoclonal Antibodies Market Outlook, By Production Type (2016-2026) ($MN)
43 Asia Pacific Monoclonal Antibodies Market Outlook, By Indication (2016-2026) ($MN)
44 Asia Pacific Monoclonal Antibodies Market Outlook, By Application (2016-2026) ($MN)
45 Asia Pacific Monoclonal Antibodies Market Outlook, By End User (2016-2026) ($MN)
46 South America Monoclonal Antibodies Market Outlook, By Country (2016-2026) ($MN)
47 South America Monoclonal Antibodies Market Outlook, By Source Type (2016-2026) ($MN)
48 South America Monoclonal Antibodies Market Outlook, By Production Type (2016-2026) ($MN)
49 South America Monoclonal Antibodies Market Outlook, By Indication (2016-2026) ($MN)
50 South America Monoclonal Antibodies Market Outlook, By Application (2016-2026) ($MN)
51 South America Monoclonal Antibodies Market Outlook, By End User (2016-2026) ($MN)
52 Middle East & Africa Monoclonal Antibodies Market Outlook, By Country (2016-2026) ($MN)
53 Middle East & Africa Monoclonal Antibodies Market Outlook, By Source Type (2016-2026) ($MN)
54 Middle East & Africa Monoclonal Antibodies Market Outlook, By Production Type (2016-2026) ($MN)
55 Middle East & Africa Monoclonal Antibodies Market Outlook, By Indication (2016-2026) ($MN)
56 Middle East & Africa Monoclonal Antibodies Market Outlook, By Application (2016-2026) ($MN)
57 Middle East & Africa Monoclonal Antibodies Market Outlook, By End User (2016-2026) ($MN)

Your Name:
Your Phone:
Company Name:
Country:
Your Email:
Description:

Related Reports

Global Patient Engagement Solutions Market Analysis 2020

Dec, 2020

Patient engagement solutions allow management of the healthcare information and provide access to healthcare professionals to interact with the patients....

Global Telehealth Market Analysis 2020

Dec, 2020

Telehealth is the use of digital information and communication technologies to access advanced healthcare care and manage it accordingly and...

Global Healthcare Cloud Computing Market Analysis 2020

Dec, 2020

Cloud computing can be defined as the practice of using remote servers in place of a local server or network,...

Global Healthcare IT Integration Market Analysis 2020

Dec, 2020

Healthcare IT integration can be defined as a type of medical devices category through which the physicians and doctors can...